Cancer of the cervix can be prevented and cured, can be circumvented using vaccines and screening and can be cured when recognised earlier before progress. It is imperceptibly becoming a rare disease in many developed countries; while countries in sub-Saharan Africa remain negatively impacted. Universally, cervical cancer is the third most generic cancer ranking after breast and colorectal cancer and the fourth most pervasive cause of cancer death ranking below breast, lung, and colorectal cancer. Cervical cancer incidence in Africa is high though it varies considerably by region. The predominant incidence is found in Lesotho and eSwatini, two countries that have neither controlled screening orderings nor any anticancer treatment facilities. In Lesotho by 2020 there were 451(44.9%) cases of cervical cancer from a total of 1206 of all other cancers from women of all ages and this percentage is very high. There are various strategies to regulate and prevent cervical cancer which include conventional cytology (smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV. Cytology-based and HPV screening procedures are not easy to be implemented in developing nations like Lesotho. Therefore there are elevated interests in the use of visual screening by use of acetic acid (VIA) test to identify cervical cancer in Lesotho as a developing country.
| Published in | American Journal of Nursing and Health Sciences (Volume 6, Issue 2) |
| DOI | 10.11648/j.ajnhs.20250602.11 |
| Page(s) | 19-25 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Knowledge, Cervix, Cancer of the Cervix, Cervical Testing and Circumvention, HPV
| [1] | Anorlu, R. (2018) Cervical cancer. The sub-Saharan African perspective, Reproductive Health Matters, 16: 32, 41-49, |
| [2] | Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J. & Bray, F. (2020) Estimates of incidence and mortality of cervical cancer in 2018. A worldwide analysis, 191-203. |
| [3] | Bor, J., Herbst A. J., Newell, M. L. & Bärnighausen, T. (2013). Increases in adult life expectancy in rural south Africa. Valuing the scale-up of HIV treatment. Science (2013) 339(6122): 961–5. |
| [4] | Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J. J., Gómez, D., Muñoz, J., Bosch, F. X., & de Sanjosé, S. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Lesotho, (2021). |
| [5] | Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T., Bénard, E., Stephen, Y. S., Regan, C., Drolet, M., Gingras, G., Laprise, J. F., Torode, J., Smith, M. A., Fidarova, E., Trapani, D., Bray, F., Ilbawi, A., Broutet, N. & Hutubessy, R. Canfell, K. (2020) Mortality impact of achieving WHO cervical cancer elimination targets. A comparative modelling analysis in 78 low-income and lower-middle-income countries, (2020) 591-603. |
| [6] | Control, D. & Tube, F. (2019) Cervical cancer. Inside knowledge about gynaecologic cancer. |
| [7] | Denny, L., & Anorlu, R. (2018) Cancer epidemiology, biomarkers and prevention. Cervical Cancer in Africa, 1434-1438. |
| [8] |
Elizabeth glaser Paediatric AIDS Foundation (EGPAF). (2018) EGPAF-Lesotho Cervical Cancer Prevention Program. 2018.
https://www.pedaids.org/wp-content/uploads/2018/12/2018_CaCxFactSheet.pdf |
| [9] | Gultekin, M., Ramirez, P. T., Broutet, N. & Hutubessy, R. (2020) Gynaecological cancer. World Health Organization call for action to eliminate cervical cancer globally, (2020) 426-427. |
| [10] | Lesotho Burden of Cancer (2022) Cancer country profile 2020, (2022). |
| [11] | Lobiondo-wood, G & Haber, J. (2018) Nursing research. Methods and critical appraisal for evidence-based practice, 9th edition, St. Louis, Missouri 63043. ISBN: 978-0-323-43131-6 |
| [12] | Moodley, M. (2019) Cervical cancer in Southern Africa. The challenges, 1(1), 11-13. |
| [13] | Ndlovu, B. H. (2011) Awareness, knowledge and experiences of women regarding cervical cancer in rural kwazulu-natal, south Africa, (1). |
| [14] | Rehman, A. A. & Khalid, A. (2016) An Introduction to Research Paradigms. International Journal of Educational Investigations, 3(8) 51-59. |
| [15] | Stelzle, D., Tanaka, L., Lee, K et al. (2021) Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health. 2021; 9(2): 161-169. |
| [16] |
World Health Organization (WHO) Africa. (2019) Africa advances on goal of cervical cancer elimination across the continent. 2019.
https://www.afro.who.int/news/africa-advances-goal-cervical-cancer-elimination-across-continent |
APA Style
Potjo, L. P., Kutoane, M., Nyangu, I. (2025). Assessment of the Knowledge and Utilization of Cervical Cancer Screening Services Amongst Women in Maseru District Lesotho. American Journal of Nursing and Health Sciences, 6(2), 19-25. https://doi.org/10.11648/j.ajnhs.20250602.11
ACS Style
Potjo, L. P.; Kutoane, M.; Nyangu, I. Assessment of the Knowledge and Utilization of Cervical Cancer Screening Services Amongst Women in Maseru District Lesotho. Am. J. Nurs. Health Sci. 2025, 6(2), 19-25. doi: 10.11648/j.ajnhs.20250602.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajnhs.20250602.11,
author = {Lehlohonolo Paul Potjo and Mahlomola Kutoane and Isabel Nyangu},
title = {Assessment of the Knowledge and Utilization of Cervical Cancer Screening Services Amongst Women in Maseru District Lesotho
},
journal = {American Journal of Nursing and Health Sciences},
volume = {6},
number = {2},
pages = {19-25},
doi = {10.11648/j.ajnhs.20250602.11},
url = {https://doi.org/10.11648/j.ajnhs.20250602.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20250602.11},
abstract = {Cancer of the cervix can be prevented and cured, can be circumvented using vaccines and screening and can be cured when recognised earlier before progress. It is imperceptibly becoming a rare disease in many developed countries; while countries in sub-Saharan Africa remain negatively impacted. Universally, cervical cancer is the third most generic cancer ranking after breast and colorectal cancer and the fourth most pervasive cause of cancer death ranking below breast, lung, and colorectal cancer. Cervical cancer incidence in Africa is high though it varies considerably by region. The predominant incidence is found in Lesotho and eSwatini, two countries that have neither controlled screening orderings nor any anticancer treatment facilities. In Lesotho by 2020 there were 451(44.9%) cases of cervical cancer from a total of 1206 of all other cancers from women of all ages and this percentage is very high. There are various strategies to regulate and prevent cervical cancer which include conventional cytology (smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV. Cytology-based and HPV screening procedures are not easy to be implemented in developing nations like Lesotho. Therefore there are elevated interests in the use of visual screening by use of acetic acid (VIA) test to identify cervical cancer in Lesotho as a developing country.
},
year = {2025}
}
TY - JOUR T1 - Assessment of the Knowledge and Utilization of Cervical Cancer Screening Services Amongst Women in Maseru District Lesotho AU - Lehlohonolo Paul Potjo AU - Mahlomola Kutoane AU - Isabel Nyangu Y1 - 2025/06/16 PY - 2025 N1 - https://doi.org/10.11648/j.ajnhs.20250602.11 DO - 10.11648/j.ajnhs.20250602.11 T2 - American Journal of Nursing and Health Sciences JF - American Journal of Nursing and Health Sciences JO - American Journal of Nursing and Health Sciences SP - 19 EP - 25 PB - Science Publishing Group SN - 2994-7227 UR - https://doi.org/10.11648/j.ajnhs.20250602.11 AB - Cancer of the cervix can be prevented and cured, can be circumvented using vaccines and screening and can be cured when recognised earlier before progress. It is imperceptibly becoming a rare disease in many developed countries; while countries in sub-Saharan Africa remain negatively impacted. Universally, cervical cancer is the third most generic cancer ranking after breast and colorectal cancer and the fourth most pervasive cause of cancer death ranking below breast, lung, and colorectal cancer. Cervical cancer incidence in Africa is high though it varies considerably by region. The predominant incidence is found in Lesotho and eSwatini, two countries that have neither controlled screening orderings nor any anticancer treatment facilities. In Lesotho by 2020 there were 451(44.9%) cases of cervical cancer from a total of 1206 of all other cancers from women of all ages and this percentage is very high. There are various strategies to regulate and prevent cervical cancer which include conventional cytology (smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV. Cytology-based and HPV screening procedures are not easy to be implemented in developing nations like Lesotho. Therefore there are elevated interests in the use of visual screening by use of acetic acid (VIA) test to identify cervical cancer in Lesotho as a developing country. VL - 6 IS - 2 ER -
Department of Nursing, National University of Lesotho, Maseru, Lesotho
Information